Cargando…
Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
INTRODUCTION: Cerebral amyloid angiopathy (CAA) is associated with symptomatic intracerebral haemorrhage. Biomarkers of clinically silent bleeding events, such as cerebrospinal fluid (CSF) ferritin and iron, might provide novel measures of disease presence and severity. METHODS: We performed an expl...
Autores principales: | Banerjee, Gargi, Forsgard, Niklas, Ambler, Gareth, Keshavan, Ashvini, Paterson, Ross W., Foiani, Martha S., Toombs, Jamie, Heslegrave, Amanda, Thompson, Edward J., Lunn, Michael P., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M., Werring, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857160/ https://www.ncbi.nlm.nih.gov/pubmed/34292397 http://dx.doi.org/10.1007/s00415-021-10711-6 |
Ejemplares similares
-
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2020) -
Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios
por: Toombs, Jamie, et al.
Publicado: (2018) -
Clinical considerations in early-onset cerebral amyloid angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2023) -
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
por: Paterson, Ross W., et al.
Publicado: (2018) -
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
por: Woollacott, Ione O. C., et al.
Publicado: (2018)